ARTICLE | Clinical News
Marduox maxacalcitol/betamethasone butyrate propionate regulatory update
April 11, 2016 7:00 AM UTC
Japan approved an NDA from Chugai for Marduox maxacalcitol/betamethasone butyrate propionate to treat psoriasis vulgaris. The product is a topical combination of Oxarol maxacalcitol, an active vitamin...